Press Release

Institut Pasteur Korea and Korea University Guro Hospital Put forces on Developing Infectious Disease Therapeutics and Vaccines

2024-08-09

PDF Download

Institut Pasteur Korea and Korea
University Guro Hospital Put forces on
Developing Infectious Disease Therapeutics and Vaccines

(Aug 9, 2024, Gyeonggi-do, Rep. of Korea) Institut Pasteur Korea (IPK) signed an MOU with Korea University Guro Hospital on the 8th with the aim of developing treatments and vaccines for infectious diseases.

At IPK, the CEO Sung Key Jang, the CSO Dimitri Lavillette, and Seungtaek Kim, the Head of the Zoonotic Virus Lab, participated, while at Korea University Guro Hospital, President Hee-Jin Cheong, Sung Beom Ko, Vice President for Medical Research, and Joon Young Song, Professor of Infectious Diseases, were in attendance.

Through this agreement, the two organizations will widely explore opportunities for joint research in treatment and vaccine development, as well as antibiotic resistance, to prepare and respond to (re)emerging infectious diseases. Additionally, they will work together to utilize infectious disease pathogens and patient specimens to advance public health and the healthcare industry.

IPK CEO, Dr. Jang said, "Institut Pasteur Korea is at the forefront of developing therapeutics and vaccines for (re)emerging infectious diseases, leveraging its basic and translational research capabilities and global network." He added, "Through this collaboration, we look forward to linking the expertise in non-clinical and clinical research to create and enhance the synergy."

President of Korea University Guro Hospital Dr. Cheong stated, “Korea University Guro Hospital has been leading in treating patients and developing vaccines during the outbreaks of new infectious diseases such as Swine influenza, Middle East Respiratory Syndrome(MERS), and COVID-19. I hope we can collaborate to uncover the mechanisms of these diseases and develop new treatments.

LIST